This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (15)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

New Information, More Questions

Neil M. Bressler, MD

Arch Ophthalmol. 1997;115(8):1071-1072.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

IN THIS ISSUE of the ARCHIVES, investigators¹ continue to explore the effect of surgical removal of subfoveal choroidal neovascularization (CNV) in patients with the ocular histoplasmosis syndrome (OHS). The ultimate aim of these efforts^1-6 is not to improve vision, but to provide a better outcome than if no surgery was performed, with an acceptable risk-benefit ratio. In the series by Berger et al,¹ 12 months after submacular surgery, 29% of eyes evaluated had improved by 2 or more Snellen lines of visual acuity while only 13% had worsened by 2 or more lines. These outcomes may be judged to be good for a condition in which subretinal fibrovascular tissue is proliferating beneath the center of the foveal avascular zone and which has been considered untreatable prior to consideration of submacular surgery. However, as discussed by the authors,¹ without an adequate reference or

See page 991 . . . [Full Text PDF of this Article]

Author Affiliations
Baltimore, Md

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?